MYRIAD GENETICS INC (MYGN)       18.21  -0.2 (-1.09%)

18.21  -0.2 (-1.09%)

US62855J1043 - Common Stock - After market: 18.21 0 (0%)

TTM
(2022-6-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-6-30)
2018
(2018-6-30)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-17.60M-27.20M-53.10M4.60M131.10M
Depreciation Amortization
53.40M62.80M35.80M73.00M54.40M
Income Taxes - Deferred
-31.20M-32.10M44.20M18.60M-23.50M
Taxes Paid
3.80M-85.40M1.80M6.50M11.70M
OPERATING CASH FLOW
-146.00M18.20M-73.70M83.70M115.90M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Other Investing Activity
231.20M292.40M35.90M-277.80M-3.20M
INVESTING CASH FLOW
211.80M274.40M28.00M-286.40M-11.60M
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
-106.40M-226.40MN/A225.00M-90.00M
Stock Issued/Repurchased
28.50M80.30M-2.00M-41.30M36.90M
Other Financing Activity
0.00-4.50M-100.00K-1.40M-41.90M
FINANCING CASH FLOW
-77.90M-150.60M-2.10M182.30M-95.00M
 
Exchange Rate Effect
-1.10M-600.00K1.10M2.70M-800.00K
CHANGE IN CASH
-13.20M141.40M-46.70M-17.70M8.50M
 
CHANGE IN WORKING CAPITAL
-78.80M120.40M-131.80M-37.10M-21.60M
 
FREE CASH FLOW
Operating Cash Flow
-146.00M18.20M-73.70M83.70M115.90M
Capital Expenditure
-19.40M-18.00M-7.90M-8.60M-8.40M
FREE CASH FLOW
-165.40M200.00K-81.60M75.10M107.50M

All data in USD

Charts